Effect of SGLT-2 Inhibitors on Non-alcoholic Fatty Liver Disease among Patients with Type 2 Diabetes Mellitus: Systematic Review with Meta-analysis and Trial Sequential Analysis of Randomized Clinical Trials

Effect of SGLT-2 Inhibitors on Non-alcoholic Fatty Liver Disease among Patients with Type 2 Diabetes Mellitus: Systematic Review with Meta-analysis and Trial Sequential Analysis of Randomized Clinical Trials

Objectives: Non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) is a common problem associated with obesity and type 2 diabetes mellitus (T2DM). There have been anecdotal reports of the efficacy of sodium-glucose cotransporter 2 inhibitors (SGLT2Is) in improving liver f...

Full description

Bibliographic Details
Main Authors: Kai Wei Lee, Navin Kumar Devaraj, Siew Mooi Ching, Sajesh K Veettil, Fan Kee Hoo, Inas Deuraseh, Man Jun Soo
Format: Article
Language:English
Published: Oman Medical Specialty Board 2021-05-01
Series:Oman Medical Journal
Subjects:
non-alcoholic fatty liver disease
sodium-glucose transporter 2 inhibitors
canagliflozin
Online Access:http://omjournal.org/articleDetails.aspx?coType=1&aId=2929

Internet

http://omjournal.org/articleDetails.aspx?coType=1&aId=2929

Similar Items